Article
Sonoma Bio inks $75M deal with Regeneron to advance cell therapies against autoimmunity
Rating:
0.0
Views:
70
Likes:
1
Library:
1
The news: Sonoma Biotherapeutics is partnering with Regeneron to co-develop cell therapies for Crohn's disease and other autoimmune conditions. The agreement comes with a $75 million upfront payment and a…
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value